Optimizing Decision Making for Ductal Carcinoma in Situ: Facts Over Fear. J Natl Cancer Inst. 2021 May 04; 113(5):511-512.
View in:
PubMed
A Phase 1 Dose-Escalation Trial of Radiation Therapy and Concurrent Cisplatin for Stage II and III Triple-Negative Breast Cancer. Int J Radiat Oncol Biol Phys. 2021 09 01; 111(1):45-52.
View in:
PubMed
Deep-learning system to improve the quality and efficiency of volumetric heart segmentation for breast cancer. NPJ Digit Med. 2021 Mar 05; 4(1):43.
View in:
PubMed
Association between the 21-gene recurrence score and isolated locoregional recurrence in stage I-II, hormone receptor-positive breast cancer. Radiat Oncol. 2020 Aug 17; 15(1):198.
View in:
PubMed
Author's Reply to Letters to the Editor by Ding and Li, and Sopik, Giannakeas, and Narod. J Natl Compr Canc Netw. 2020 05; 18(5):xliiib-xlivb.
View in:
PubMed
Location as Destiny: Identifying Geospatial Disparities in Radiation Treatment Interruption by Neighborhood, Race, and Insurance. Int J Radiat Oncol Biol Phys. 2020 07 15; 107(4):815-826.
View in:
PubMed
Neoadjuvant treatment strategies for HER2-positive breast cancer: cost-effectiveness and quality of life outcomes. Breast Cancer Res Treat. 2020 May; 181(1):43-51.
View in:
PubMed
Commentary: Creating a patient-centered decision aid for ductal carcinoma in situ. Breast J. 2020 07; 26(7):1498-1499.
View in:
PubMed
Cost Effectiveness of DCISionRT for Guiding Treatment of Ductal Carcinoma in Situ. JNCI Cancer Spectr. 2020 Apr; 4(2):pkaa004.
View in:
PubMed
Mortality After Invasive Second Breast Cancers Following Prior Radiotherapy for DCIS. J Natl Compr Canc Netw. 2019 11 01; 17(11):1367-1371.
View in:
PubMed
Patient-preferred outcomes measurement after post-mastectomy radiation therapy and immediate reconstruction. Breast J. 2020 02; 26(2):319-321.
View in:
PubMed
Long-term outcomes of breast-conserving therapy for women with ductal carcinoma in situ. Breast Cancer Res Treat. 2019 Dec; 178(3):607-615.
View in:
PubMed
Impact of Health-Related Quality of Life and Prediagnosis Risk of Major Depressive Disorder on Treatment Choice for Stage I Lung Cancer. JCO Clin Cancer Inform. 2019 09; 3:1-8.
View in:
PubMed
Effects of Postmastectomy Radiation Therapy on Immediate Tissue Expander and Acellular Dermal Matrix Reconstruction: Results of a Prospective Clinical Trial. Pract Radiat Oncol. 2019 Sep - Oct; 9(5):338-346.
View in:
PubMed
Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS). JNCI Cancer Spectr. 2018 Nov; 2(4):pky063.
View in:
PubMed
Cost Effectiveness of the Oncotype DX Genomic Prostate Score for Guiding Treatment Decisions in Patients With Early Stage Prostate Cancer. Urology. 2019 04; 126:89-95.
View in:
PubMed
Impact of pre-diagnosis depressive symptoms and health-related quality of life on treatment choice for ductal carcinoma in situ and stage I breast cancer in older women. Breast Cancer Res Treat. 2019 Feb; 173(3):709-717.
View in:
PubMed
Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic Cancer. Ann Surg Oncol. 2018 Dec; 25(13):4027-4034.
View in:
PubMed
Estrogen-receptor status and risk of contralateral breast cancer following DCIS. Breast Cancer Res Treat. 2018 Oct; 171(3):777-781.
View in:
PubMed
Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series. Ann Surg Oncol. 2018 Nov; 25(12):3527-3534.
View in:
PubMed
Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys. 2018 07 15; 101(4):875-882.
View in:
PubMed
Treating Second Breast Events After Breast-Conserving Surgery for Ductal Carcinoma in Situ. J Natl Compr Canc Netw. 2018 04; 16(4):387-394.
View in:
PubMed
Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches. Med Decis Making. 2018 04; 38(1_suppl):126S-139S.
View in:
PubMed
Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery. Breast Cancer Res Treat. 2018 02; 167(3):751-759.
View in:
PubMed
Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study. JAMA Oncol. 2017 Aug 01; 3(8):1069-1077.
View in:
PubMed
Cost-Effectiveness of Surveillance for Distant Recurrence in Extremity Soft Tissue Sarcoma. Ann Surg Oncol. 2017 Oct; 24(11):3264-3270.
View in:
PubMed
Breast cancer prevention strategies in lobular carcinoma in situ: A decision analysis. Cancer. 2017 Jul 15; 123(14):2609-2617.
View in:
PubMed
The Impact of Reexcision and Residual Disease on Local Recurrence Following Breast-Conserving Therapy. Ann Surg Oncol. 2017 Jul; 24(7):1868-1873.
View in:
PubMed
Nature of Medical Malpractice Claims Against Radiation Oncologists. Int J Radiat Oncol Biol Phys. 2017 05 01; 98(1):21-30.
View in:
PubMed
Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation. JAMA Oncol. 2017 Jan 01; 3(1):101-104.
View in:
PubMed
Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy. Breast Cancer Res Treat. 2017 01; 161(1):173-179.
View in:
PubMed
Cost Effectiveness of the Oncotype DX DCIS Score for Guiding Treatment of Patients With Ductal Carcinoma In Situ. J Clin Oncol. 2016 11 20; 34(33):3963-3968.
View in:
PubMed
Reply to comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer. Cancer. 2016 10 15; 122(20):3244-3245.
View in:
PubMed
Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer. Cancer. 2016 Jul 01; 122(13):2091-100.
View in:
PubMed
The Role of Intraoperative Pathologic Assessment in the Surgical Management of Ductal Carcinoma In Situ. Ann Surg Oncol. 2016 09; 23(9):2788-94.
View in:
PubMed
Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community. Breast Cancer Res Treat. 2016 Feb; 155(3):541-9.
View in:
PubMed
Factors associated with radiation therapy incompletion for patients with early-stage breast cancer. Breast Cancer Res Treat. 2016 Jan; 155(1):187-99.
View in:
PubMed
onlineDeCISion.org: a web-based decision aid for DCIS treatment. Breast Cancer Res Treat. 2015 Nov; 154(1):181-90.
View in:
PubMed
Prospective assessment of deep inspiration breath-hold using 3-dimensional surface tracking for irradiation of left-sided breast cancer. Pract Radiat Oncol. 2015 Nov-Dec; 5(6):358-65.
View in:
PubMed
Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database. Int J Radiat Oncol Biol Phys. 2015 Nov 01; 93(3):622-30.
View in:
PubMed
Effect of lymph node metastasis size on breast cancer-specific and overall survival in women with node-positive breast cancer. Breast Cancer Res Treat. 2015 Jul; 152(1):209-216.
View in:
PubMed
Medical Malpractice Claims in Radiation Oncology: A Population-Based Study 1985-2012. Int J Radiat Oncol Biol Phys. 2015 Oct 01; 93(2):241-50.
View in:
PubMed
Outcome following local-regional recurrence in women with early-stage breast cancer: impact of biologic subtype. Breast J. 2015 Mar-Apr; 21(2):161-7.
View in:
PubMed
Management of older women with early-stage breast cancer. Am Soc Clin Oncol Educ Book. 2015; 48-55.
View in:
PubMed
Management of the regional lymph nodes following breast-conservation therapy for early-stage breast cancer: an evolving paradigm. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):772-7.
View in:
PubMed
Dosimetric Inhomogeneity Predicts for Long-Term Breast Pain After Breast-Conserving Therapy. Int J Radiat Oncol Biol Phys. 2015 Dec 01; 93(5):1087-95.
View in:
PubMed
Cost-effectiveness analysis of SBRT versus IMRT for low-risk prostate cancer. Am J Clin Oncol. 2014 Jun; 37(3):215-21.
View in:
PubMed
Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ. Ann Surg Oncol. 2014 Nov; 21(12):3766-73.
View in:
PubMed
Decision analysis and cost-effectiveness analysis for comparative effectiveness research--a primer. Semin Radiat Oncol. 2014 Jan; 24(1):14-24.
View in:
PubMed
Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate? J Natl Cancer Inst. 2013 Oct 16; 105(20):1527-33.
View in:
PubMed
Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice. Breast Cancer Res Treat. 2013 Oct; 141(3):421-7.
View in:
PubMed
Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy. Breast Cancer Res Treat. 2013 Jul; 140(2):353-61.
View in:
PubMed
Modeling the effectiveness of initial management strategies for ductal carcinoma in situ. J Natl Cancer Inst. 2013 Jun 05; 105(11):774-81.
View in:
PubMed
Trade-offs associated with axillary lymph node dissection with breast irradiation versus breast irradiation alone in patients with a positive sentinel node in relation to the risk of non-sentinel node involvement: implications of ACOSOG Z0011. Breast Cancer Res Treat. 2013 Feb; 138(1):205-13.
View in:
PubMed
American Society for Radiation Oncology's Performance Assessment for the Advancement of Radiation Oncology Treatment: A practical approach for informing practice improvement. Pract Radiat Oncol. 2013 Apr-Jun; 3(2):e37-43.
View in:
PubMed
Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):e109-16.
View in:
PubMed
Trade-offs associated with axillary lymph node dissection: Implications of the eligibility versus enrollment in ACOSOG Z0011. J Clin Oncol. 2012 Sep 20; 30(27_suppl):151.
View in:
PubMed
Impact of margin status on local recurrence after mastectomy for ductal carcinoma in situ. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):948-52.
View in:
PubMed
Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ. Cancer. 2012 Dec 15; 118(24):6022-30.
View in:
PubMed
Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ. Int J Radiat Oncol Biol Phys. 2012 Mar 15; 82(4):e581-6.
View in:
PubMed
Accelerated partial breast irradiation using brachytherapy for breast cancer: patterns in utilization and guideline concordance. J Natl Cancer Inst. 2012 Jan 04; 104(1):29-41.
View in:
PubMed
Accelerated partial breast irradiation using brachytherapy (APBIb) for breast cancer (bca): Predictors of use and guideline concordance. J Clin Oncol. 2011 Sep 20; 29(27_suppl):84.
View in:
PubMed
Should a sentinel node biopsy be performed in patients with high-risk breast cancer? Int J Breast Cancer. 2011; 2011:973245.
View in:
PubMed
Radiation therapy for ductal carcinoma in situ: a decision analysis. Cancer. 2012 Feb 01; 118(3):603-11.
View in:
PubMed
Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: population-based practices and treatment effectiveness. Cancer. 2012 Jan 01; 118(1):248-57.
View in:
PubMed
Effect of very small tumor size on cancer-specific mortality in node-positive breast cancer. J Clin Oncol. 2011 Jul 01; 29(19):2619-27.
View in:
PubMed
Accelerated partial-breast irradiation using brachytherapy (APBIb) for breast cancer (BCA): Predictors of use and guideline concordance. J Clin Oncol. 2011 May 20; 29(15_suppl):6080.
View in:
PubMed
Pathologic characteristics of second breast cancers (SBC) among women previously treated for ductal carcinoma in situ (DCIS) with breast conservation. J Clin Oncol. 2011 May 20; 29(15_suppl):1042.
View in:
PubMed
Adoption of intensity-modulated radiation therapy for breast cancer in the United States. J Natl Cancer Inst. 2011 May 18; 103(10):798-809.
View in:
PubMed
Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2011 Dec 01; 81(5):e767-74.
View in:
PubMed
Using lifetime risk estimates to recommend magnetic resonance imaging screening for breast cancer survivors. J Clin Oncol. 2010 Sep 20; 28(27):4108-10.
View in:
PubMed
Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis. BMJ. 2010 Mar 02; 340:c845.
View in:
PubMed
Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer. Ann Oncol. 2010 May; 21(5):1072-7.
View in:
PubMed
Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors. J Clin Oncol. 2009 Nov 10; 27(32):5383-9.
View in:
PubMed
Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis. Int J Radiat Oncol Biol Phys. 2009 Jun 01; 74(2):440-6.
View in:
PubMed
Influence of year of diagnosis, patient age, and sociodemographic status on recommending adjuvant radiation treatment for stage I testicular seminoma. J Clin Oncol. 2008 Aug 20; 26(24):3937-42.
View in:
PubMed
Factors associated with guideline-concordant use of radiotherapy after mastectomy in the national comprehensive cancer network. Int J Radiat Oncol Biol Phys. 2008 Dec 01; 72(5):1434-40.
View in:
PubMed
Cost-effectiveness of partial breast irradiation versus whole breast irradiation for early-stage breast cancer. J Clin Oncol. 2008 May 20; 26(15_suppl):6530.
View in:
PubMed
Predictors and effect of delay in initiation of radiation therapy (RT) after breast-conserving surgery (BCS) in elderly women. J Clin Oncol. 2008 May 20; 26(15_suppl):6515.
View in:
PubMed
Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis. J Natl Cancer Inst. 2008 May 07; 100(9):642-8.
View in:
PubMed
Prostate-specific antigen velocity and the detection of gleason score 7 to 10 prostate cancer. Cancer. 2007 Nov 01; 110(9):1973-8.
View in:
PubMed
Partial breast irradiation versus whole breast radiotherapy for early-stage breast cancer: a decision analysis. Int J Radiat Oncol Biol Phys. 2008 Feb 01; 70(2):469-76.
View in:
PubMed
Local therapy and survival in breast cancer. N Engl J Med. 2007 Jun 07; 356(23):2399-405.
View in:
PubMed
Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity. Int J Radiat Oncol Biol Phys. 2007 Apr 01; 67(5):1299-308.
View in:
PubMed
Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease. J Clin Oncol. 2006 Sep 01; 24(25):4116-22.
View in:
PubMed
Radiation therapy after mastectomy between 1991 and 1999 in elderly women: response to clinical trial information. J Clin Oncol. 2006 Jul 20; 24(21):3474-82.
View in:
PubMed
Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women. Int J Radiat Oncol Biol Phys. 2006 Sep 01; 66(1):56-63.
View in:
PubMed
Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women. J Clin Oncol. 2006 Jun 20; 24(18_suppl):6030.
View in:
PubMed
The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis. Cancer. 2006 Jun 15; 106(12):2576-82.
View in:
PubMed
Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level. Cancer. 2006 Apr 01; 106(7):1507-13.
View in:
PubMed
Operating characteristics of prostate-specific antigen and verification bias. JAMA. 2005 Dec 07; 294(21):2698; author reply 2698-9.
View in:
PubMed
Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis. J Clin Oncol. 2005 Aug 01; 23(22):5178-87.
View in:
PubMed
Optimizing endocrine therapy in postmenopausal women with early stage breast cancer: A decision analysis for biological subsets of tumors. J Clin Oncol. 2005 Jun; 23(16_suppl):529.
View in:
PubMed
Determination of mean population values of the prostate-specific antigen test after correcting for verification bias. J Clin Oncol. 2005 Jun; 23(16_suppl):6031.
View in:
PubMed
. Choosing the best adjuvant endocrine treatment strategy for patients with postmenopausal breast cancer: A decision analysis. In: Perry MC, ed. American Society of Clinical Oncology Educational Book. 2005; 40-44.
Factors associated with appropriate use of radiation therapy after mastectomy in women with Stage I-II breast cancer treated within the National Comprehensive Cancer Network (NCCN). J Clin Oncol. 2004 Jul 15; 22(14_suppl):6032.
View in:
PubMed
Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med. 2003 Jul 24; 349(4):335-42.
View in:
PubMed
Radiation therapy plus tamoxifen versus tamoxifen alone after breast-conserving surgery in postmenopausal women with stage I breast cancer: a decision analysis. J Clin Oncol. 2003 Jun 15; 21(12):2260-7.
View in:
PubMed
Integrating surgery and radiotherapy to reduce toxicity while maintaining local control for breast cancer: a fine balance. Ann Surg Oncol. 2002 Jul; 9(6):526-8.
View in:
PubMed
Regulation of vascular endothelial growth factor expression by insulin-like growth factor I. Diabetes. 1997 Oct; 46(10):1619-26.
View in:
PubMed